These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31427038)

  • 21. Thyroid hemiagenesis with Graves' disease, Graves' ophthalmopathy and multinodular goiter.
    Cakir M; Gonen S; Dikbas O; Ozturk B
    Intern Med; 2009; 48(12):1047-9. PubMed ID: 19525596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid status, cardiovascular risk, and mortality in older adults.
    Cappola AR; Fried LP; Arnold AM; Danese MD; Kuller LH; Burke GL; Tracy RP; Ladenson PW
    JAMA; 2006 Mar; 295(9):1033-41. PubMed ID: 16507804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
    Bürgi U; Gerber H; Peter HJ
    Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relevance of cause of hyperthyroidism in determining its management.
    Veneman TF; Weymer M; Tjabbes T; van Haeften TW
    Neth J Med; 1989 Dec; 35(5-6):303-8. PubMed ID: 2635287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical aspects of hyperthyroidism in areas of different supplies of iodine. Results of a European prospective study].
    Reinwein D; Benker G; König MP; Pinchera A; Schatz H; Schleusener H
    Schweiz Med Wochenschr; 1987 Aug; 117(34):1245-55. PubMed ID: 3672070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subclinical Hyperthyroidism and the Cardiovascular Disease.
    Delitala AP
    Horm Metab Res; 2017 Oct; 49(10):723-731. PubMed ID: 28915531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Subclinical thyroid disease].
    Nakajima Y; Yamada M
    Nihon Rinsho; 2012 Nov; 70(11):1865-71. PubMed ID: 23214054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemodynamic changes following treatment of subclinical and overt hyperthyroidism.
    Faber J; Wiinberg N; Schifter S; Mehlsen J
    Eur J Endocrinol; 2001 Oct; 145(4):391-6. PubMed ID: 11580994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Goiter Dispersion Formula on Serum Cytokines in Hyperthyroidism Patients with Neurologic Manifestations of Graves' Disease: A Randomized Trial on 80 Cases.
    Tian WH; Wang Y; Yang R; Hu HB
    J Altern Complement Med; 2018 May; 24(5):481-485. PubMed ID: 29406821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and causes of undiagnosed hyperthyroidismin an adult healthy population. The Tromsø study.
    Bjørndal MM; Sandmo Wilhelmsen K; Lu T; Jorde R
    J Endocrinol Invest; 2008 Oct; 31(10):856-60. PubMed ID: 19092288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study.
    Carlé A; Pedersen IB; Knudsen N; Perrild H; Ovesen L; Rasmussen LB; Laurberg P
    Eur J Endocrinol; 2011 May; 164(5):801-9. PubMed ID: 21357288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The transformation of Basedow's struma into nodular goiter: a reason for recurrence of hyperthyroidism].
    Studer H; Huber G; Derwahl M; Frey P
    Schweiz Med Wochenschr; 1989 Feb; 119(7):203-8. PubMed ID: 2652283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to Graves' Disease and Nontoxic Goiter.
    Giesecke P; Rosenqvist M; Frykman V; Friberg L; Wallin G; Höijer J; Lönn S; Törring O
    Thyroid; 2017 Jul; 27(7):878-885. PubMed ID: 28471268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: a comparison with Graves' disease.
    van Soestbergen MJ; van der Vijver JC; Graafland AD
    J Endocrinol Invest; 1992 Dec; 15(11):797-800. PubMed ID: 1283983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The many causes of subclinical hyperthyroidism.
    Charkes ND
    Thyroid; 1996 Oct; 6(5):391-6. PubMed ID: 8936661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular involvement in patients with different causes of hyperthyroidism.
    Biondi B; Kahaly GJ
    Nat Rev Endocrinol; 2010 Aug; 6(8):431-43. PubMed ID: 20585347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges in the Management of Atrial Fibrillation With Subclinical Hyperthyroidism.
    Gencer B; Cappola AR; Rodondi N; Collet TH
    Front Endocrinol (Lausanne); 2021; 12():795492. PubMed ID: 35058884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays.
    Pedersen IB; Knudsen N; Perrild H; Ovesen L; Laurberg P
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):381-90. PubMed ID: 11589682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.